433 related articles for article (PubMed ID: 12490665)
1. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
2. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
3. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1 mg and 2 mg overnight dexamethasone suppression tests for the screening of Cushing's syndrome in obese patients.
Sahin M; Kebapcilar L; Taslipinar A; Azal O; Ozgurtas T; Corakci A; Akgul EO; Taslipinar MY; Yazici M; Kutlu M
Intern Med; 2009; 48(1):33-9. PubMed ID: 19122354
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome.
Kungpanichkul N
J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome. Screening methods in hospitalized patients.
Dunlap NE; Grizzle WE; Siegel AL
Arch Pathol Lab Med; 1985 Mar; 109(3):222-9. PubMed ID: 3838451
[TBL] [Abstract][Full Text] [Related]
7. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
[TBL] [Abstract][Full Text] [Related]
9. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of endocrine tests. B: screening for hypercortisolism.
Holleman F; Endert E; Prummel MF; van Vessem-Timmermans M; Wiersinga WM; Fliers E
Neth J Med; 2005 Oct; 63(9):348-53. PubMed ID: 16244382
[TBL] [Abstract][Full Text] [Related]
12. [Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].
Contreras LN; Cardoso E; Lozano MP; Pozzo J; Pagano P; Claus-Hermbeg H
Medicina (B Aires); 2000; 60(3):326-30. PubMed ID: 11050809
[TBL] [Abstract][Full Text] [Related]
13. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.
Trilck M; Flitsch J; Lüdecke DK; Jung R; Petersenn S
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):225-30. PubMed ID: 15891959
[TBL] [Abstract][Full Text] [Related]
14. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity.
Grossman A; Howlett TA; Kopelman PG
Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293
[TBL] [Abstract][Full Text] [Related]
15. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
[TBL] [Abstract][Full Text] [Related]
16. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
[TBL] [Abstract][Full Text] [Related]
17. Cushing's syndrome in a clinic population with diabetes.
Newsome S; Chen K; Hoang J; Wilson JD; Potter JM; Hickman PE
Intern Med J; 2008 Mar; 38(3):178-82. PubMed ID: 17645502
[TBL] [Abstract][Full Text] [Related]
18. Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus.
Reimondo G; Pia A; Allasino B; Tassone F; Bovio S; Borretta G; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2007 Aug; 67(2):225-9. PubMed ID: 17547690
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
20. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
